Eighth Annual Chapel Hill Pharmaceutical Sciences Conference
The UNC Eshelman School of Pharmacy will host the Eighth Annual Chapel Hill Pharmaceutical Sciences Conference on May 28-29, 2014, at the Carolina Club on the campus of the University of North Carolina at Chapel Hill. This year’s theme will be pharmacoengineering.
The conference, formerly named the Chapel Hill Drug Conference, offers an intimate setting for exchanging ideas on future research and developments emanating from the interface of engineering and the pharmaceutical sciences with many of the leaders in the field. Researchers and students interested in learning what pharmacoengineering and the Research Triangle have to offer are encouraged to attend.
- Karen Aboody (Associate Professor, City of Hope)
- Tosh Chilkoti (Theo Pilkington Professor, Duke)
- Paul Dayton (Professor, UNC/NCSU)
- Joe Desimone (Chancellor's Eminent Professor of Chemistry, UNC)
- Dennis Discher (Robert D. Bent chaired Professor, UPenn)
- Bill Egan (Former Director, Office of Vaccines Research and Review, FDA)
- Leonard Friedland (Vice President, Scientific Affairs & Public Health for North America Vaccines, GSK)
- Tony Hickey (Distinguished Fellow, RTI International)
- Leaf Huang (Fred Eshelman Distinguished Professor, UNC)
- Darrell Irvine (Professor, MIT & HHMI Investigator)
- Sam Lai (Assistant Professor, UNC)
- Derek O’Hagan (Global Head of Vaccine Delivery Research, Novartis Vaccines)
- A. Krishna Prasad (Director, Vaccine Research and Early Phase Development, Pfizer Vaccines)
- W. Mark Saltzman (Goizueta Foundation Professor, Yale)
- David Volkin (Takeru and Aya Higuchi Distinguished Professor, University of Kansas)
- Kay Wagoner (President, Wagoner Discovery and Development Consulting)
- Jennifer West (Fitzpatrick Family University Professor, Duke)
- Liangfang Zhang (Associate Professor, UCSD)
The conference will include
- talks on biological barriers, biologically inspired systems, translational development, and physical principles in pharmacoengineering;
- student poster sessions during lunch, a student-run symposium in the evening, and student awards; and
- a vaccine-focused symposium co-hosted with Novartis Vaccines.
Pharmacoengineering is the interdisciplinary application and convergence of pharmaceutical sciences and engineering to discover and implement innovative technologies for delivering therapeutics. R&D in the pharmaceutical industry has undergone substantial changes over the past decade, led by an increasing transfer of health-care research from large enterprises to small companies, academic labs, and startups from inventions in academia. It is increasingly obvious that a research initiative integrating engineering methods with pharmaceutical sciences is necessary to respond to this rapidly shifting landscape. To address the current trend and future unmet training needs in biomedical research, the UNC Eshelman School of Pharmacy has established a pharmacoengineering program with the UNC/NCSU Dept of Biomedical Engineering.
Download our mobile app to stay up to date on conference information.
- Sam Lai, PhD (Committee Chair), Assistant Professor, UNC Eshelman School of Pharmacy
- Michael Jay, PhD, Fred Eshelman Distinguished Professor, UNC Eshelman School of Pharmacy
- Zishan Haroon, MD, PhD, Director, Carolina Center for Nanotechnology Excellence
- Manmohan Singh, PhD, Head of Drug Product Development, Novartis Vaccines
Scientific Advisory Committee
Faculty of the Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy